The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 18, 2014

Filed:

Nov. 18, 2010
Applicants:

Bing Lim, Singapore, SG;

Jianyong Han, Singapore, SG;

Wai-leong Tam, Singapore, SG;

Inventors:

Bing Lim, Singapore, SG;

Jianyong Han, Singapore, SG;

Wai-Leong Tam, Singapore, SG;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); C12N 5/02 (2006.01); C12N 5/071 (2010.01); C12N 5/07 (2010.01); C12N 5/10 (2006.01); C12N 5/074 (2010.01); C12N 15/00 (2006.01); A01K 67/027 (2006.01); C12N 15/873 (2010.01);
U.S. Cl.
CPC ...
C12N 5/0696 (2013.01); C12N 15/00 (2013.01); C12N 2501/00 (2013.01); C12N 2506/00 (2013.01); A01K 67/0271 (2013.01); C12N 15/873 (2013.01); C12N 2501/60 (2013.01); C12N 2501/602 (2013.01); C12N 2501/603 (2013.01); C12N 2501/604 (2013.01); C12N 2510/00 (2013.01); C12N 2799/027 (2013.01);
Abstract

We provide for the use of Tbx3 (GenBank Accession Number: NM_005996.3 (SEQ ID NO. 1), NP_005987.3 (SEQ ID NO. 2), NM_016569.3 (SEQ ID NO. 3), NP_057653.3 (SEQ ID NO. 4)) in a method of enhancing or inducing pluripotency in a cell such as a somatic cell. We describe a method of reprogramming a cell, the method comprising modulating the expression and/or activity of Tbx3 in the cell. The cell may become a pluripotent cell such as a stem cell. We further describe a method of causing a cell such as a somatic cell to display one or more characteristics of a pluripotent cell, the method comprising modulating the expression and/or activity of Tbx3 in the cell. The method may further comprise modulating the expression and/or activity of one or more, a combination of or all of Oct4, Sox2 and Klf4 in the cell.


Find Patent Forward Citations

Loading…